CytRx Closes $74.75M CMPO at 19% Discount via Jefferies-led Deal

CytRx Corporation (CYTR) announced that it has raised $74,750,000 in a CMPO/Overnight transaction. The common stock was sold at $6.50 per share, an approximate 19% discount to the market price ($7.98) of CYTR at deal announcement. Jefferies & Company acted as Sole Book-Running Manager with Oppenheimer, Aegis Capital, and H.C. Wainwright as Co-Lead Managers on the transaction. Underwriter counsel was Latham & Watkins and issuer counsel was TroyGould. The transaction is expected to close on February 5, 2014. via PlacementTracker.

Regado Bioscience Raises $20M at 20% Discount via Cowen, BMO

Regado Bioscience, Inc. (RGDO) announced that it has raised $20,000,000 in a Common Stock transaction. The common stock was sold at $5.00 per share, an approximate 20% discount to the market price ($6.25) of RGDO at deal announcement. Cowen and Company, LLC acted as the Lead Agent with BMO Capital Markets Corp. acting as Co-Agent on the transaction. Issuer counsel was Lowenstein Sandler, PC and Goodwin Procter was Placement Agent Counsel. Note this Placement is subject to customary closing conditions and is expected to close by 02/05/2014. via PlacementTracker.

Arch Therapeutics Raises $2.85M at 34% Discount from Cranshire Capital, Heng Hong

Arch Therapeutics, Inc. (ARTH) announced that it has raised $2,850,000 in a Common Stock transaction. The common stock was sold at $0.25 per share, an approximate 34% discount to the market price ($0.38) of ARTH at deal announcement. A series of 11,400,000 60-Month Warrants with an exercise price of $0.30 per share (21.05% discount) were issued to the investors in this transaction. An additional series of 11,400,000 12-Month Warrants with an exercise price of $0.35 per share (7.89% discount) were issued to the investors in this transaction. An additional series of 11,400,000 18-Month Warrants with and exercise price of $0.40 per share (5.26% premium) were issued to the investors in this transaction.

UQM Technologies Raises $5.3M in RDO via HC Wainwright

UQM Technologies, Inc. (UQM) announced that it has raised $5,300,000 in a Registered Direct transaction. The common stock was sold at $1.85 per share, an approximate 11% discount to the market price ($2.09) of UQM at deal announcement. A series of 1,432,433 60-Month Warrants with an exercise price of $2.13 per share (1.79% premium) was issued to the investors in this transaction. H.C. Wainwright & Co., LLC acted as the exclusive agent on the transaction. The Placement is subject to customary closing conditions and is expected to close by 02/05/2014. via PlacementTracker.